{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:53:45Z","timestamp":1772121225323,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.medcli.2021.06.012","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T07:27:47Z","timestamp":1624001267000},"page":"509-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab"],"prefix":"10.1016","volume":"158","author":[{"given":"Adri\u00e1n","family":"S\u00e1nchez-Montalv\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falia","family":"Sellar\u00e9s-Nadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Espinosa-Pereiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Fern\u00e1ndez-Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"P\u00e9rez-Hoyos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Dur\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Miarons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Ant\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sime\u00f3n","family":"Eremiev-Eremiev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abiu","family":"Sempere-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnau","family":"Monforte-Pallar\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pau","family":"Bosch-Nicolau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falia","family":"Sampol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Guill\u00e9n-del-Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benito","family":"Almirante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2021.06.012_bib0190","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.medcli.2021.06.012_bib0195","unstructured":"Weekly epidemiological update on COVID-19-13 April 2021 s. f."},{"key":"10.1016\/j.medcli.2021.06.012_bib0200","unstructured":"Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi Zhonghua Liuxingbingxue Zazhi. 2020;41:145\u201351."},{"key":"10.1016\/j.medcli.2021.06.012_bib0205","doi-asserted-by":"crossref","first-page":"e1003189","DOI":"10.1371\/journal.pmed.1003189","article-title":"Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: a modeling study in Hubei China, and six regions in Europe","volume":"14","author":"Hauser","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.medcli.2021.06.012_bib0210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/14787210.4.2.291","article-title":"Potential antivirals and antiviral strategies against SARS coronavirus infections","volume":"4","author":"De Clercq","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.medcli.2021.06.012_bib0215","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/14787210.2017.1271712","article-title":"Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)","volume":"15","author":"Al-Tawfiq","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.medcli.2021.06.012_bib0220","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"105949","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medcli.2021.06.012_bib0225","article-title":"Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial","author":"Chen","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.medcli.2021.06.012_bib0230","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.medcli.2021.06.012_bib0235","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2021.06.012_bib0240","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.medcli.2021.06.012_bib0245","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2021.06.012_bib0250","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S0140-6736(20)30305-6","article-title":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option","volume":"395","author":"Zumla","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.medcli.2021.06.012_bib0255","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/DDDT.S150580","article-title":"Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection","volume":"13","author":"Biggioggero","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.medcli.2021.06.012_bib0260","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2021.06.012_bib0265","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial","author":"Horby","year":"2021","journal-title":"Infect Dis (except HIV\/AIDS)"},{"key":"10.1016\/j.medcli.2021.06.012_bib0270","article-title":"Interleukin-6 receptor antagonists in critically ill patients with Covid-19","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2021.06.012_bib0275","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.medcli.2021.06.012_bib0280","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2021.06.012_bib0285","unstructured":"World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. WHO \u2013 Interim Guid. 2020;2019:1\u20137."},{"key":"10.1016\/j.medcli.2021.06.012_bib0290","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2334-5-6","article-title":"A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium","volume":"5","author":"Mo\u00ebs","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medcli.2021.06.012_bib0295","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/JVI.02351-13","article-title":"Discovery of a novel bottlenose dolphin coronavirus reveals a distinct species of marine mammal coronavirus in Gammacoronavirus","volume":"88","author":"Woo","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.medcli.2021.06.012_bib0300","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin definition","volume":"307","author":"Force","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2021.06.012_bib0305","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0885066613516411","article-title":"SpO2\/FiO2 ratio on hospital admission is an indicator of early acute respiratory distress syndrome development among patients at risk","volume":"30","author":"Festic","year":"2013","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.medcli.2021.06.012_bib0310","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4742","article-title":"Treating COVID-19-Off-Label drug use compassionate use, and randomized clinical trials during pandemics","author":"Kalil","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2021.06.012_bib0315","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cmi.2020.08.010","article-title":"Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)","volume":"27","author":"Rodr\u00edguez-Ba\u00f1o","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medcli.2021.06.012_bib0320","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","author":"Grein","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2021.06.012_bib0325","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2021.06.012_bib0330","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.medcli.2021.06.012_bib0335","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.medcli.2021.06.012_bib0340","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4812","article-title":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?","author":"Patel","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2021.06.012_bib0345","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2021.06.012_bib0350","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1056\/NEJMoa2028836","article-title":"Efficacy of tocilizumab in patients hospitalized with Covid-19","volume":"383","author":"Stone","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2021.06.012_bib0355","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamainternmed.2020.6615","article-title":"Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial","volume":"181","author":"Salvarani","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.medcli.2021.06.012_bib0360","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1440-1843.2010.01720.x","article-title":"The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status","volume":"15","author":"Ngai","year":"2010","journal-title":"Respirol Carlton Vic"},{"key":"10.1016\/j.medcli.2021.06.012_bib0365","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2008.092866","article-title":"Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study","volume":"68","author":"Nishimoto","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2021.06.012_bib0370","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMsb2005114","article-title":"Fair allocation of scarce medical resources in the time of Covid-19","author":"Emanuel","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775321003602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775321003602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:53:54Z","timestamp":1758419634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775321003602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0025775321003602"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2021.06.012","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.07.20094599","asserted-by":"object"}]},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2021.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}